👨⚕ Ángel Carracedo (Santiago de Compostela, Spain)
Chairpersons:
👨⚕ Rafael Bañares (Madrid, Spain)
👨⚕Francisco Jorquera (León, Spain)
Is there a need for specialized units?
👨⚕ Manuel Romero (Sevilla, Spain)
The role of the geneticist
👩⚕️ Nerea Paz (Santander, Spain)
Chairpersons:
👨⚕ Conrado Fernández (Madrid, Spain)
👨⚕ José Presa (Vila Real, Portugal)
Natural history in PBC
👨⚕ Christophe Corpechot (Paris, France)
Personalized treatment in PBC
👨⚕ Gideon M. Hirschfield (Toronto, Canada)
Chairpersons:
👩⚕ María Buti (Barcelona, Spain)
👨⚕ Rafael Esteban (Barcelona, Spain)
Do we know the natural history of delta hepatitis?
👨⚕ José Luis Calleja (Madrid, Spain)
Therapeutic options in hepatitis delta
👨⚕ Marc Bourlière (Marseille, France)
Real Life experience in Hepatitis delta treatment
👨⚕ Pietro Lampertico (Milan, Italy)
Porto-sinusoidal vascular disease (PSVD)
👩⚕ Virginia Hernández-Gea (Barcelona, Spain)
Fontan associated liver disease
👨⚕ Luis Téllez (Madrid, Spain)
Coffee Break & Visit Art Exhibition
Chairpersons:
👩⚕ Marina Berenguer (Valencia, Spain)
👩⚕ Elba Llop (Madrid, Spain)
What is the best treatment for Wilson’s disease today?
👨⚕ Michael L. Schilsky (New Haven, United States)
Do real-life registries improve care?
👩⚕ Zoe Mariño (Barcelona, Spain)
Chairpersons:
👨⚕ Jose Luis Calleja (Madrid, Spain)
👨⚕ JavierCrespo (Santander,Spain)
👨⚕ Julio Mayol (Madrid, Spain) v.s Clinical experts and audience
Chairpersons:
👨⚕ Jesús Bañales (San Sebastián, Spain)
👨⚕Raúl Andrade (Málaga, Spain)
Genetics of alpha 1 AT deficiency
👨⚕ Pavel Strnad (Aachen, Germany)
Progressive familial intrahepadc cholestasis
👨⚕ Richard J. Thompson (London, England)
New therapeutic options in Polycistic Liver disease
👨⚕ Joost Drenth (Nijmegen, Netherlands)
Hereditary hemochromatosis pathogenesis
👩⚕ Elena Corradini (Modena, Italy)
Chairpersons:
👩⚕ Ángela Puente (Santander, Spain)
👨⚕ Agustín Albillos (Madrid, Spain)
Integrate genomic data into clinical practice
👨⚕ Luca Valenti (Milan, Italy)
How to discover a disease: From the patient’s bedside to the laboratory
The clinician’s question
👨⚕ Álvaro Díaz (Santander, Spain)
The basic’s answer
👨⚕ José Juan García Marín (Salamanca, Spain)
MASLD genetic risk variants and personalized treatment
👨⚕ Stefano Romeo (Catanzaro, Italy)
New approaches for the treatment of liver diseases
👩⚕ Mariluz Martínez-Chantar (Derio, Spain)
Chairpersons:
👩⚕ María Teresa Arias Loste (Santander, Spain)
👨⚕ Marcos López Hoyos (Santander, Spain)
One million genomes project
👨⚕ André G. Uitterlinden (Rotterdam, Netherlands)
Cohorte Cantabria
👨⚕ Marcos López Hoyos (Santander, Spain)
👨⚕ José Luis Calleja (Madrid, Spain)
👨⚕ Javier Crespo (Santander, Spain)
🌍 Venue Information
Centro Botín
Muelle de Albareda s/n
Jardines de Pereda
Santander (Spain)
📌 SYMPOSIUM SECRETARIAT
c/Sor Ángela de la Cruz 8-28020 Madrid (Spain)
📞 +34 915551119
✉ congresos@viajesoasis.com 🌐https://viajesoasis.com/